Understanding how a specific receptor affects allergic responses in women
P2X3 is a Female-Dominant Amplifier of Mast Cell Function
This study is looking at how a specific receptor in immune cells called P2X3 affects allergic reactions, especially in women, to help understand why women often have stronger allergies and asthma; they're also exploring if a common antidepressant, fluoxetine, can help improve these allergic responses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-10887430 on NIH RePORTER |
What this research studies
This research investigates the role of the P2X3 receptor in mast cell function, particularly focusing on how it amplifies allergic responses in females. The study aims to understand why female mast cells exhibit stronger reactions to allergens compared to males, which may contribute to the higher prevalence of allergic asthma in women. By examining the effects of fluoxetine, a common antidepressant, on mast cell activation, the researchers hope to identify new therapeutic targets for treating allergic diseases. The approach includes both laboratory experiments and analysis of human mast cells to validate findings.
Who could benefit from this research
Good fit: Ideal candidates for this research are women experiencing allergic asthma or related allergic conditions.
Not a fit: Patients who do not have allergic diseases or who are male may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for allergic diseases that are more effective for women.
How similar studies have performed: Previous research has shown promising results in understanding sex differences in immune responses, suggesting that this approach could yield valuable insights.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Ryan, John J — Virginia Commonwealth University
- Study coordinator: Ryan, John J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.